Clin2
NCT07065409Possibly a fitRecruiting

Exosomes for Moyamoya disease treatment trial

Moyamoya Disease

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests whether exosomes made from special stem cells can help people with Moyamoya disease who still have symptoms after surgery. It aims to improve blood flow to the brain and reduce future strokes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
9 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old and have Moyamoya disease confirmed by imaging tests like MRI or angiogram.
  • You have already had a surgery called temporal muscle patch but did not get enough improvement.
  • It has been at least 3 months since your surgery, and tests show poor blood flow or ongoing brain ischemia.
  • You still have symptoms of Moyamoya disease, such as mini-strokes (TIAs) or stroke-like episodes.
  • Your blood and organ function tests are within safe ranges for the trial.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06634004Enrolling by invitation
Using biomarkers to improve surgery outcomes in Moyamoya

This study at Vanderbilt tests whether certain biomarkers (signs in your blood or brain scans) can help tailor care for people with Moyamoya, a condition where blood flow to the brain is reduced. Participants will have brain scans and complete study procedures before and after surgery to improve blood flow.

Baltimore, Maryland
NCT07762547Not yet recruiting
Aspirin and arm cuff therapy for mild moyamoya disease

This trial tests whether a daily aspirin regimen combined with a blood-pressure cuff treatment on the arm can slow the progression of mild moyamoya disease. It aims to reduce the risk of strokes and bleeding events.

Beijing, Beijing Municipality
NCT05332756Recruiting
Long-term follow-up of moyamoya care and family health

This trial follows people with moyamoya disease who are treated with medication only, and it also looks at first-degree relatives. The goal is to understand long-term outcomes and whether careful conservative care is beneficial over time.

Beijing, Beijing Municipality
NCT07286110Not yet recruiting· Phase 1
Chinese herbal treatment for moyamoya disease: CHIMES trial

This trial tests whether a Chinese herbal formula called Qiqi Shengmai can help people with moyamoya disease, a rare condition where blood vessels in the brain become narrow. It aims to see if the herbal treatment is safe and may improve symptoms.

Shanghai, Shanghai Municipality
NCT06051552Not yet recruiting
Predicting recovery after moyamoya brain surgery

This study is building a tool to predict how people with moyamoya disease will do after brain surgery to improve blood flow. If you are an adult with moyamoya and are scheduled for this surgery, you may be able to help.

Beijing
NCT05619068Recruiting
Study tracking outcomes in Moyamoya disease

This study looks at how Moyamoya disease changes over time and what predicts outcomes. It uses approved brain imaging and, likely, thinking/memory tests to understand prognosis.

Beijing, Beijing Municipality

Hear when a new Moyamoya Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.